Poh C B,Tan P C,Kam J W,et al.Regional citrate anticoagulation for continuous renal replacement therapy-a safe and effective low-dose protocol[J].Nephrology (Carlton),2020,25(4):305-313.
[7]
Mehta R L,McDonald B R,Aguilar M M,et al.Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients[J].Kidney Int,1990,38(5):976-981.
[8]
Liu C,Mao Z,Kang H,et al.Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients:a meta-analysis with trial sequential analysis of randomized controlled trials[J].Crit Care,2016,20(1):144.
[9]
Slowinski T,Morgera S,Joannidis M,et al.Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure:the Liver Citrate Anticoagulation Threshold (L-CAT) observational study[J].Crit Care,2015,19:349.
[10]
Ricci D,Panicali L,Facchini M G,et al.Citrate anticoagulation during continuous renal replacement therapy[J].Contrib Nephrol,2017,190:19-30.
Faguer S,Saint C M,Nogier M B,et al.Heparin-free prolonged intermittent hemodialysis using calcium-free citrate dialysate in critically ill patients[J].Crit Care Med,2017,45(11):1887-1892.
Degraeve A,Danse E,Laterre P F,et al.Regional citrate anticoagulation and influence of recirculation on ionized calcium levels in the circuit[J].J Artif Organs,2019,22(4):341-344.
[23]
Klingele M,Seiler S,Poppleton A,et al.The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss-a case report[J].BMC Nephrol,2014,15:163.
[24]
Strobl K,Harm S,Weber V,et al.The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters[J].Int J Artif Organs,2017,40(1):15-21.
[25]
Klingele M,Stadler T,Fliser D,et al.Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction[J].Crit Care,2017,21(1):294.
[26]
Tan J N,Haroon S W P,Mukhopadhyay A,et al.Hyperlactatemia predicts citrate intolerance with regional citrate anticoagulation during continuous renal replacement therapy[J].J Intensive Care Med,2019,34(5):418-425.
Mariano F,Tedeschi L,Morselli M,et al.Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients[J].Intensive Care Med,2010,36(10):1735-1743.
[32]
Meier-Kriesche H U,Gitomer J,Finkel K,et al.Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation[J].Crit Care Med,2001,29(4):748-752.
[33]
Zhang W,Bai M,Yu Y,et al.Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients:a systematic review and meta-analysis[J].Crit Care,2019,23(1):22.
2021, Vol. 32 
